Clinical Trial Update: Oxaliplatin in Treating Patients With Liver Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating oxaliplatin for hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer | Phase 2 | Status: COMPLETED